BlackRock Institutional Trust’s Sinovac Biotech, Ltd SVA Stock Holding History

BlackRock Institutional Trust’s Portfolio SVA Stock Details SVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-24,460	Closed	-$121K	–	4072
2015 Q1	$121K	Hold	24,460	–	–	﹤0.01%	3686
2014 Q4	$128K	Sell	24,460 -2,433	-9%	-$12.4K	﹤0.01%	3693
2014 Q3	$129K	Sell	26,893 -3,378	-11%	-$18.1K	﹤0.01%	3658
2014 Q2	$171K	Buy	30,271 +6,063	+25%	+$36.8K	﹤0.01%	3717
2014 Q1	$174K	Sell	24,208 -3,415	-12%	-$22.6K	﹤0.01%	3717
2013 Q4	$169K	Buy	27,623 +1,621	+6%	+$9.77K	﹤0.01%	3745
2013 Q3	$155K	Sell	26,002 -10,523	-29%	-$50.3K	﹤0.01%	3715
2013 Q2	$144K	Buy	+36,525	New	+$136K	﹤0.01%	3690

Other funds holding SVA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

BlackRock Institutional Trust's SVA Position: Q2 2015 in Review

BlackRock Institutional Trust sold out of Sinovac Biotech, Ltd (SVA) in Q2 2015, closing a stake of 24,460 shares — an estimated $121K sold.

BlackRock Institutional Trust first reported a position in SVA in Q2 2013 and held it in 8 quarters. The position peaked at $174K in Q1 2014. 37 funds tracked by Wall St. Rank hold SVA as of Q2 2015.

BlackRock Institutional Trust reported no remaining Sinovac Biotech, Ltd position as of Q2 2015 after selling out during the quarter.
BlackRock Institutional Trust sold 24,460 Sinovac Biotech, Ltd shares in Q2 2015, an estimated $121K.
BlackRock Institutional Trust first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 8 quarters.
BlackRock Institutional Trust's Sinovac Biotech, Ltd position peaked at $174K in Q1 2014.
37 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q2 2015.

Based on BlackRock Institutional Trust's 13F filing for Q2 2015, filed 7 Aug 2015.